{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:58:16Z","timestamp":1783403896168,"version":"3.54.6"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ejrad.2023.110852","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T21:01:25Z","timestamp":1683147685000},"page":"110852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["MRI-informed prostate biopsy: What the radiologist should know on quality in biopsy planning and biopsy acquisition"],"prefix":"10.1016","volume":"164","author":[{"given":"Rossano","family":"Girometti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Giannarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Peruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Amparore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Pizzolitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Zuiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejrad.2023.110852_b0005","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eururo.2019.06.023","article-title":"Prostate magnetic resonance imaging, with or without magnetic resonance imaging-targeted biopsy, and systematic biopsy for detecting prostate cancer: a cochrane systematic review and meta-analysis","volume":"77","author":"Drost","year":"2020","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejrad.2023.110852_b0010","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.eururo.2020.03.048","article-title":"Negative predictive value of multiparametric magnetic resonance imaging in the detection of clinically significant prostate cancer in the prostate imaging reporting and data system era: a systematic review and metanalysis","volume":"78","author":"Sathianathen","year":"2020","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.ejrad.2023.110852_b0015","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.euo.2020.12.004","article-title":"Positive predictive value of prostate imaging reporting and data system version 2 for the detection of clinically significant prostate cancer: a systematic review and meta-analysis","volume":"4","author":"Mazzone","year":"2021","journal-title":"Eur. Urol. Oncol."},{"issue":"4","key":"10.1016\/j.ejrad.2023.110852_b0020","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1007\/s00330-021-08535-z","article-title":"Balancing the benefits and harms of MRI-directed biopsy pathways","volume":"32","author":"Padhani","year":"2022","journal-title":"Eur. Radiol."},{"issue":"6","key":"10.1016\/j.ejrad.2023.110852_b0025","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.eururo.2021.09.007","article-title":"A future prebiopsy imaging-guided pathway to safely omit systematic biopsies and prevent diagnosis of indolent prostate cancer","volume":"80","author":"Hagens","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejrad.2023.110852_b0030","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1007\/s00330-020-07527-9","article-title":"A multifacted approach to quality in the MRI-directed biopsy pathway fo prostate cancer diagnosis","volume":"31","author":"Padhani","year":"2021","journal-title":"Eur. Radiol."},{"issue":"4","key":"10.1016\/j.ejrad.2023.110852_b0035","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.eururo.2020.09.015","article-title":"Measuring the quality of diagnostic prostate magnetic resonance imaging: a urologist\u2019s perspective","volume":"79","author":"Giannarini","year":"2021","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.ejrad.2023.110852_b0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41585-022-00648-4","article-title":"Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway","volume":"20","author":"Barrett","year":"2023","journal-title":"Nat. Rev. Urol."},{"issue":"3","key":"10.1016\/j.ejrad.2023.110852_b0045","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Update of prostate imaging reporting and data system version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejrad.2023.110852_b0050","unstructured":"Mottet N, Cornford P, van den Bergh RCN, et al. EAU - EANM - ESTRO - ESUR \u2013 SIOG Guidelines on Prostate Cancer. Available at https:\/\/uroweb.org\/guidelines\/prostate-cancer. Last access February 26, 2023."},{"issue":"4","key":"10.1016\/j.ejrad.2023.110852_b0055","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41585-022-00684-0","article-title":"Landmarks in the evolution of prostate biopsy","volume":"20","author":"Connor","year":"2023","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.ejrad.2023.110852_b0060","doi-asserted-by":"crossref","unstructured":"Gravestock P, Shaw M, Veeratterapillay R, Heer R. Prosatte cancer diagnosis: biopsy approaches. In: Barber N, Ali A, editors. Urologic Cancers [Internet]. Brisbane (AU): Exon Publications; 2022 Sep 12. Chapter 12.","DOI":"10.36255\/exon-publications-urologic-cancers-prostate-cancer-biopsy"},{"issue":"2","key":"10.1016\/j.ejrad.2023.110852_b0065","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/jmri.26220","article-title":"Interreader agreement of PI-RADS v. 2 in assessing prostate cancer with multiparametric MRI: a study using whole-mount histology as the standard of reference","volume":"49","author":"Girometti","year":"2019","journal-title":"J. Magn. Reson. Imaging"},{"issue":"1131","key":"10.1016\/j.ejrad.2023.110852_b0070","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210886","article-title":"Comparison of different thresholds of PSA density for risk stratification of PI-RADSv2.1 categories on prostate MRI","volume":"95","author":"Girometti","year":"2022","journal-title":"Brit. J. Radiol."},{"key":"10.1016\/j.ejrad.2023.110852_b0075","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3390\/ijms20071637","article-title":"Prediction medicine: biomarkers, risk calculators and magnetic resonance imaging as risk stratification tools in prostate cancer diagnosis","volume":"20","author":"Osses","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejrad.2023.110852_b0080","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/JU.0000000000001306","article-title":"Risk stratification of prostate cancer according to PI-RADS\u00ae version 2 categories: a meta-analysis for prospective studies","volume":"204","author":"Park","year":"2020","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.ejrad.2023.110852_b0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2214\/AJR.20.24268","article-title":"PI-RADS committee position on MRI without contrast medium in biopsy-naive men with suspected prostate cancer: narrative review","volume":"216","author":"Schoots","year":"2021","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2023.110852_b0090","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/JU.0000000000002182","article-title":"Why does magnetic resonance imaging-targeted biopsy miss clinically signicant cancer?","volume":"207","author":"Willimas","year":"2022","journal-title":"J. Urol."},{"issue":"10","key":"10.1016\/j.ejrad.2023.110852_b0095","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1007\/s00330-020-06929-z","article-title":"ESUR\/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists' training","volume":"30","author":"de Rooij","year":"2020","journal-title":"Eur. Radiol."},{"issue":"2","key":"10.1016\/j.ejrad.2023.110852_b0100","doi-asserted-by":"crossref","first-page":"e051274","DOI":"10.1136\/bmjopen-2021-051274","article-title":"Detection of ISUP \u22652 prostate cancers using multiparametric MRI: prospective multicentre assessment of the non-inferiority of an artificial intelligence system as compared to the PI-RADS vol 2.1 score (CHANGE study)","volume":"12","author":"Rouvi\u00e8re","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejrad.2023.110852_b0105","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1007\/s00261-020-02725-x","article-title":"Upcoming American College of Radiology prostate MRI designation launching: what to expect","volume":"45","author":"Tan","year":"2020","journal-title":"Abdom. Radiol."},{"key":"10.1016\/j.ejrad.2023.110852_b0110","doi-asserted-by":"crossref","unstructured":"NICE. Nice guidance \u2013 prostate cancer: diagnosis and management: \u00a9 NICE (2019) prostate cancer: diagnosis and management. BJU Int 2019;124:9-26.","DOI":"10.1111\/bju.14809"},{"issue":"11","key":"10.1016\/j.ejrad.2023.110852_b0115","doi-asserted-by":"crossref","first-page":"7544","DOI":"10.1007\/s00330-022-08822-3","article-title":"Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsy","volume":"32","author":"Deniffel","year":"2022","journal-title":"Eur. Radiol."},{"issue":"5","key":"10.1016\/j.ejrad.2023.110852_b0120","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.eururo.2022.07.025","article-title":"Prostate cancer detection percentages of repeat biopsy in patients with positive multiparametric magnetic resonance imaging (Prostate Imaging Reporting and Data System\/Likert 3\u20135) and negative initial biopsy. a mini systematic review","volume":"82","author":"Grivas","year":"2022","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.ejrad.2023.110852_b0125","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.juro.2016.08.097","article-title":"Missing the mark: prostate cancer upgrading by systematic biopsy over magnetic resonance imaging\/transrectal ultrasound fusion biopsy","volume":"197","author":"Muthigi","year":"2017","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.ejrad.2023.110852_b0130","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1089\/end.2017.0694","article-title":"Assessment of needle tip deflection during transrectal guided prostate biopsy: implications for targeted biopsies","volume":"32","author":"Halstuch","year":"2018","journal-title":"J. Endourol."},{"issue":"6","key":"10.1016\/j.ejrad.2023.110852_b0135","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.eururo.2016.12.006","article-title":"Why and where do we miss significant prostate cancer with multi-parametric magnetic resonance imaging followed by magnetic resonance-guided and transrectal ultrasound-guided biopsy in biopsy-na\u00efve men?","volume":"71","author":"Schouten","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejrad.2023.110852_b0140","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1111\/bju.12637","article-title":"Detection of the index tumor and tumor volume in prostate cancer using T2-weighted and diffusion-weightd magntic rsonance imaging (MRI) alone","volume":"114","author":"Rud","year":"2014","journal-title":"BJU Int."},{"issue":"2","key":"10.1016\/j.ejrad.2023.110852_b0145","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.juro.2015.02.080","article-title":"Image guided focal therapy for magnetic resonance imaging visible prostate cancer: defining a 3-dimensional treatment margin based on magnetic resonance imaging histology co-registration analysis","volume":"194","author":"Le Nobin","year":"2015","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.ejrad.2023.110852_b0150","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.juro.2016.07.084","article-title":"Magnetic resonance imaging underestimation of prostate cancer geometry: use of patient specific molds to correlate images with whole mount pathology","volume":"197","author":"Priester","year":"2017","journal-title":"J. Urol."},{"issue":"4","key":"10.1016\/j.ejrad.2023.110852_b0155","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.juro.2017.10.048","article-title":"Risk of upgrading from prostate biopsy to radical prostatectomy pathology-does saturation biopsy of index lesion during multiparametric magnetic resonance imaging-transrectal ultrasound fusion biopsy help?","volume":"199","author":"Calio","year":"2018","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.ejrad.2023.110852_b0160","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2022.01.008","article-title":"Targeted prostate biopsy: umbra, penumbra, and value of perilesional sampling","volume":"82","author":"Brisbane","year":"2022","journal-title":"Eur. Urol."},{"issue":"3","key":"10.1016\/j.ejrad.2023.110852_b0165","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/JU.0000000000001406","article-title":"Application of the PRECISION trial biopsy strategy to a contemporary magnetic resonance imaging-targeted biopsy cohort-how many clinically significant prostate cancers are missed?","volume":"205","author":"Feuer","year":"2021","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.ejrad.2023.110852_b0170","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.eururo.2019.04.008","article-title":"Role of core number and location in targeted magnetic resonance imaging-ultrasound fusion prostate biopsy","volume":"76","author":"Lu","year":"2019","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.ejrad.2023.110852_b0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1148\/radiol.2019180712","article-title":"Value of increasing biopsy cores per target with cognitive MRI-targeted transrectal US prostate biopsy","volume":"291","author":"Zhang","year":"2019","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ejrad.2023.110852_b0180","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/jcm9010225","article-title":"Assessment of the minimal targeted biopsy core number per MRI lesion for improving prostate cancer grading prediction","volume":"9","author":"Ploussard","year":"2020","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.ejrad.2023.110852_b0185","doi-asserted-by":"crossref","first-page":"193.e1","DOI":"10.1016\/j.urolonc.2020.09.019","article-title":"Optimizing MRI-targeted prostate biopsy: the diagnostic benefit of additional targeted biopsy cores","volume":"39","author":"Tracy","year":"2021","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.ejrad.2023.110852_b0190","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/bju.14865","article-title":"Optimising the number of cores for magnetic resonance imaging-guided targeted and systematic transperineal prostate biopsy","volume":"125","author":"Hansen","year":"2020","journal-title":"BJU Int."},{"issue":"2","key":"10.1016\/j.ejrad.2023.110852_b0195","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.eururo.2021.01.039","article-title":"Perilesional biopsies increase detection of significant prostate cancer in men with PI-RADS 4\/5 lesions: validation of the PI-RADS steering committee recommendation","volume":"80","author":"Lahoud","year":"2021","journal-title":"Eur. Urol."},{"issue":"6","key":"10.1016\/j.ejrad.2023.110852_b0200","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.euf.2020.06.020","article-title":"Detection of significant prostate cancer using target saturation in transperineal magnetic resonance imaging\/transrectal ultrasonography-fusion biopsy","volume":"7","author":"Tschirdewahn","year":"2021","journal-title":"Eur. Urol. Focus"},{"issue":"1","key":"10.1016\/j.ejrad.2023.110852_b0205","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.euo.2022.08.005","article-title":"Detection of clinically significant prostate cancer using targeted biopsy with four cores versus target saturation biopsy with nine cores in transperineal prostate fusion biopsy: a prospective randomized trial","volume":"6","author":"Saner","year":"2023","journal-title":"Eur. Urol. Oncol."},{"issue":"3","key":"10.1016\/j.ejrad.2023.110852_b0210","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.eururo.2018.05.035","article-title":"Prostate imaging-reporting and data system steering committee: PI-RADS v2 status update and future directions","volume":"75","author":"Padhani","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejrad.2023.110852_b0215","doi-asserted-by":"crossref","first-page":"368","DOI":"10.21037\/tau.2017.03.58","article-title":"Transperineal vs. trabsrectal biopsy in MRI targeting","volume":"6","author":"Grummet","year":"2017","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.ejrad.2023.110852_b0220","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.euros.2022.01.001","article-title":"Role of prophylactic antibiotics in transperineal prostate biopsy: a systematic review and meta-analysis","volume":"37","author":"Basourakos","year":"2022","journal-title":"Eur. Urol. Open Sci."},{"issue":"10","key":"10.1016\/j.ejrad.2023.110852_b0225","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S1473-3099(22)00373-5","article-title":"Antibiotic prophylaxis versus no antibiotic prophylaxis in transperineal prostate biopsies (NORAPP): a randomised, open-label, non-inferiority trial","volume":"22","author":"Jacewicz","year":"2022","journal-title":"Lancet Infect. Dis."},{"issue":"4","key":"10.1016\/j.ejrad.2023.110852_b0230","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/bju.15562","article-title":"Clinical implementation of pre-biopsy magnetic resonance imaging pathways for the diagnosis of prostate cancer","volume":"129","author":"Isra\u00ebl","year":"2022","journal-title":"BJU Int."},{"issue":"5","key":"10.1016\/j.ejrad.2023.110852_b0235","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0090-4295(02)01525-X","article-title":"Anterior distribution of Stage T1c nonpalpable tumors in radical prostatectomy specimens","volume":"59","author":"Takashima","year":"2002","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.ejrad.2023.110852_b0240","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/JU.0000000000000156","article-title":"Transperineal prostate biopsies using local anesthesia: experience with 1,287 patients. prostate cancer detection rate, complications and patient tolerability","volume":"201","author":"Stefanova","year":"2019","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.ejrad.2023.110852_b0245","doi-asserted-by":"crossref","DOI":"10.1186\/s12894-022-01011-w","article-title":"A comparative study of transperineal software-assisted magnetic resonance\/ultrasound fusion biopsy and transrectal cognitive fusion biopsy of the prostate","volume":"22","author":"Hsieh","year":"2022","journal-title":"BMC Urol."},{"issue":"8","key":"10.1016\/j.ejrad.2023.110852_b0250","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.urolonc.2020.04.005","article-title":"A systematic review and meta-analysis of magnetic resonance imaging and ultrasound guided fusion biopsy of prostate for cancer detection-Comparing transrectal with transperineal approaches","volume":"38","author":"Loy","year":"2020","journal-title":"Urol. Oncol."},{"issue":"5","key":"10.1016\/j.ejrad.2023.110852_b0255","doi-asserted-by":"crossref","first-page":"e860","DOI":"10.1016\/j.clgc.2019.05.006","article-title":"Transperineal magnetic resonance imaging-targeted biopsy may perform better than transrectal route in the detection of clinically significant prostate cancer: systematic review and meta-analysis","volume":"17","author":"Tu","year":"2019","journal-title":"Clin. Genitourin Cancer"},{"key":"10.1016\/j.ejrad.2023.110852_b0260","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.euo.2020.12.012","article-title":"Magnetic resonance imaging\/ultrasound fusion-guided transperineal versus magnetic resonance imaging\/ultrasound fusion-guided transrectal biopsy \u2013 a systematic review","volume":"4","author":"Rai","year":"2021","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.ejrad.2023.110852_b0265","first-page":"3291","article-title":"Multiparametric MRI\/TRUS fusion prostate biopsy: advantages of a transperineal approach","volume":"37","author":"Pepe","year":"2017","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.ejrad.2023.110852_b0270","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41391-020-0205-7","article-title":"A noninferiority within-person study comparing the accuracy of transperineal to transrectal MRI-US fusion biopsy for prostate-cancer detection","volume":"23","author":"Ber","year":"2020","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"4","key":"10.1016\/j.ejrad.2023.110852_b0275","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/JU.0000000000002802","volume":"208","author":"Zattoni","year":"2022","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.ejrad.2023.110852_b0280","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.eururo.2007.02.041","article-title":"Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy","volume":"52","author":"Merrick","year":"2007","journal-title":"Eur. Urol."},{"issue":"6","key":"10.1016\/j.ejrad.2023.110852_b0285","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1097\/JU.0000000000000474","article-title":"Transperineal prostate biopsies using local anesthesia: experience with 1,287 patients. prostate cancer detection rate, complications and patient tolerability","volume":"202","author":"Moro","year":"2019","journal-title":"J. Urol."},{"key":"10.1016\/j.ejrad.2023.110852_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/17562872221105019","article-title":"Schema and cancer detection rates for transperineal prostate biopsy templates: a review","volume":"14","author":"Sidana","year":"2022","journal-title":"Ther. Adv. Urol."},{"key":"10.1016\/j.ejrad.2023.110852_b0295","first-page":"799","article-title":"Recent advances in systematic and targeted prostate biopsies","volume":"13","author":"Devetzis","year":"2021","journal-title":"Res. Rep. Urol."},{"key":"10.1016\/j.ejrad.2023.110852_b0300","doi-asserted-by":"crossref","unstructured":"Djavan B, Prostate Biopsies and the Vienna Nomograms. Eur Urol Suppl, Technical Aspects of Urooncological Interventions 2006;5, 500\u2013510.","DOI":"10.1016\/j.eursup.2006.02.018"},{"issue":"5","key":"10.1016\/j.ejrad.2023.110852_b0305","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/bju.12132","article-title":"Definitions of terms, processes and a minimum dataset for transperineal prostate biopsies: a standardization approach of the Ginsburg Study Group for Enhanced Prostate Diagnostics","volume":"112","author":"Kuru","year":"2013","journal-title":"BJUI"},{"issue":"5","key":"10.1016\/j.ejrad.2023.110852_b0310","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.eururo.2015.12.052","article-title":"Multiparametric Magnetic Resonance Imaging (MRI) and MRI-transrectal ultrasound fusion biopsy for index tumor detection: correlation with radical prostatectomy specimen","volume":"70","author":"Radtke","year":"2016","journal-title":"Eur. Urol."},{"issue":"3","key":"10.1016\/j.ejrad.2023.110852_b0315","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.21037\/tau.2019.07.16","article-title":"Value of systematic sampling in an mp-MRI targeted prostate biopsy strategy","volume":"9","author":"Connor","year":"2020","journal-title":"Transl. Androl. Urol."},{"issue":"2-3","key":"10.1016\/j.ejrad.2023.110852_b0320","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/21681805.2019.1600581","article-title":"Magnetic resonance imaging-transrectal ultrasound image fusion guidance of prostate biopsies: current status, challenges and future perspectives","volume":"53","author":"Boesen","year":"2019","journal-title":"Scand. J. Urol."},{"issue":"2","key":"10.1016\/j.ejrad.2023.110852_b0325","doi-asserted-by":"crossref","first-page":"e200123","DOI":"10.1148\/rycan.2021200123","article-title":"Gleason grade group concordance between preoperative targeted biopsy and radical prostatectomy histopathologic analysis: a comparison between in-bore MRI-guided and MRI-transrectal US fusion prostate biopsies","volume":"3","author":"Costa","year":"2021","journal-title":"Radiol. Imaging Cancer"},{"key":"10.1016\/j.ejrad.2023.110852_b0330","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2214\/AJR.14.12681","article-title":"Evaluation of MRI-TRUS fusion versus congitive registration accuracy for MRI-targeted, TRUS-guided prostate biopsy","volume":"204","author":"Cool","year":"2015","journal-title":"AJR Am. J. Roentgenol."},{"issue":"1","key":"10.1016\/j.ejrad.2023.110852_b0335","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/iju.14127","article-title":"Magnetic resonance imaging-guided targeted prostate biopsy: Comparison between computer-software-based fusion versus cognitive fusion technique in biopsy-na\u00efve patients","volume":"27","author":"Yamada","year":"2020","journal-title":"Int. J. Urol."},{"issue":"4","key":"10.1016\/j.ejrad.2023.110852_b0340","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.eururo.2018.11.040","article-title":"The FUTURE trial: a multicenter randomised controlled trial on target biopsy techniques based on magnetic resonance imaging in the diagnosis of prostate cancer in patients with prior negative biopsies","volume":"75","author":"Wegelin","year":"2019","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.ejrad.2023.110852_b0345","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.eururo.2013.10.048","article-title":"A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial","volume":"66","author":"Wysock","year":"2014","journal-title":"Eur. Urol."},{"issue":"3","key":"10.1016\/j.ejrad.2023.110852_b0350","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.juro.2016.03.149","article-title":"Comparative effectiveness of targeted prostate biopsy using magnetic resonance imaging ultrasound fusion software and visual targeting: a prospective study","volume":"196","author":"Lee","year":"2016","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.ejrad.2023.110852_b0355","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.euo.2018.02.002","article-title":"Not all multiparametric magnetic resonance imaging-targeted biopsies are equal: the impact of the type of approach and operator expertise on the detection of clinically significant prostate cancer","volume":"1","author":"Stabile","year":"2018","journal-title":"Eur. Urol. Oncol."},{"issue":"6","key":"10.1016\/j.ejrad.2023.110852_b0360","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.juro.2018.07.001","article-title":"Accuracy of transperineal targeted prostate biopsies, visual estimation and image fusion in men needing repeat biopsy in the PICTURE trial","volume":"200","author":"Simmons","year":"2018","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.ejrad.2023.110852_b0365","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1148\/radiol.2017162916","article-title":"Precision matters in MR imaging-targeted prostate biopsies: evidence from a prospective study of cognitive and elastic fusion registration transrectal biopsies","volume":"287","author":"Cornud","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2023.110852_b0370","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamasurg.2019.1734","article-title":"Comparison of targeted vs systematic prostate biopsy in men who are biopsy naive: the prospective assessment of image registration in the diagnosis of prostate cancer (PAIREDCAP) study","volume":"154","author":"Elkhoury","year":"2019","journal-title":"JAMA Surg."},{"issue":"5","key":"10.1016\/j.ejrad.2023.110852_b0375","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.eururo.2018.08.007","article-title":"The SmartTarget biopsy trial: a prospective, within-person randomised, blinded trial comparing the accuracy of visual-registration and magnetic resonance imaging\/ultrasound image-fusion targeted biopsies for prostate cancer risk stratification","volume":"75","author":"Hamid","year":"2019","journal-title":"Eur. Urol."},{"issue":"9","key":"10.1016\/j.ejrad.2023.110852_b0380","doi-asserted-by":"crossref","first-page":"734.e19","DOI":"10.1016\/j.urolonc.2020.03.020","article-title":"Systematic review and meta-analysis comparing cognitive vs. image-guided fusion prostate biopsy for the detection of prostate cancer","volume":"38","author":"Watts","year":"2020","journal-title":"Urol. Oncol."},{"issue":"2","key":"10.1016\/j.ejrad.2023.110852_b0385","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41391-021-00449-7","article-title":"Diagnostic accuracy of magnetic resonance imaging targeted biopsy techniques compared to transrectal ultrasound guided biopsy of the prostate: a systematic review and meta-analysis","volume":"25","author":"Bass","year":"2022","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"6","key":"10.1016\/j.ejrad.2023.110852_b0390","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.juro.2016.06.079","article-title":"Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR","volume":"196","author":"Rosenkrantz","year":"2016","journal-title":"J. Urol."},{"key":"10.1016\/j.ejrad.2023.110852_b0395","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3348\/kjr.2019.0817","article-title":"MRI-targeted prostate biopsy: what radiologists should know","volume":"21","author":"Das","year":"2020","journal-title":"Korean J. Radiol."},{"key":"10.1016\/j.ejrad.2023.110852_b0400","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/bju.13247","article-title":"he value of magnetic resonance imaging and ultrasonography (MRI\/US)-fusion biopsy platforms in prostate cancer detection: a systematic review","volume":"117","author":"Gayet","year":"2016","journal-title":"BJU Int."},{"issue":"3","key":"10.1016\/j.ejrad.2023.110852_b0405","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.juro.2011.10.124","article-title":"3-Dimensional elastic registration system of prostate biopsy location by real-time 3-dimensional transrectal ultrasound guidance with magnetic resonance\/transrectal ultrasound image fusion","volume":"187","author":"Ukimura","year":"2012","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.ejrad.2023.110852_b0410","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.eururo.2014.10.026","article-title":"Detection of clinically significant prostate cancer using magnetic resonance imaging-ultrasound fusion targeted biopsy: a systematic review","volume":"68","author":"Valerio","year":"2015","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.ejrad.2023.110852_b0415","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.euf.2016.07.003","article-title":"Elastic versus rigid image registration in magnetic resonance imaging-transrectal ultrasound fusion prostate biopsy: a systematic review and meta-analysis","volume":"4","author":"Venderink","year":"2018","journal-title":"Eur. Urol. Focus"},{"issue":"1","key":"10.1016\/j.ejrad.2023.110852_b0420","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/JU.0000000000002182","article-title":"Why does magnetic resonance imaging-targeted biopsy miss clinically significant cancer?","volume":"207","author":"Williams","year":"2022","journal-title":"J. Urol."},{"issue":"5","key":"10.1016\/j.ejrad.2023.110852_b0425","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.juro.2018.06.012","article-title":"The institutional learning curve of magnetic resonance imaging-ultrasound fusion targeted prostate biopsy: temporal improvements in cancer detection in 4 years","volume":"200","author":"Meng","year":"2018","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.ejrad.2023.110852_b0430","doi-asserted-by":"crossref","first-page":"7.e19","DOI":"10.1016\/j.urolonc.2021.05.029","article-title":"Number of cores needed to diagnose prostate cancer during MRI targeted biopsy decreases after the learning curve","volume":"40","author":"Bevill","year":"2022","journal-title":"Urol. Oncol."},{"issue":"6","key":"10.1016\/j.ejrad.2023.110852_b0435","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.juro.2018.06.033","article-title":"Patient reported outcome measures for transperineal template prostate mapping biopsies in the PICTURE study","volume":"200","author":"Miah","year":"2018","journal-title":"J. Urol."},{"key":"10.1016\/j.ejrad.2023.110852_b0440","first-page":"E445","article-title":"Quantifying the effect of biopsy lateral decubitus patient positioning compared to supine prostate magnetic resonance image scanning on prostate translocation and distortion","volume":"14","author":"Snoj","year":"2020","journal-title":"Can. Urol. Assoc. J."},{"issue":"1","key":"10.1016\/j.ejrad.2023.110852_b0445","doi-asserted-by":"crossref","DOI":"10.1186\/s12894-016-0196-9","article-title":"The addition of a sagittal image fusion improves the prostate cancer detection in a sensor-based MRI \/ultrasound fusion guided targeted biopsy","volume":"17","author":"G\u00fcnzel","year":"2017","journal-title":"BMC Urol."},{"issue":"2","key":"10.1016\/j.ejrad.2023.110852_b0450","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/jmri.25948","article-title":"All over the map: an interobserver agreement study of tumor location based on the PI-RADSv2 sector map","volume":"48","author":"Greer","year":"2018","journal-title":"J. Magn. Reson. Imaging"},{"issue":"5","key":"10.1016\/j.ejrad.2023.110852_b0455","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.euo.2020.06.007","article-title":"Prostate Imaging Quality (PI-QUAL): a new quality control scoring system for multiparametric magnetic resonance imaging of the prostate from the PRECISION trial","volume":"3","author":"Giganti","year":"2020","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.ejrad.2023.110852_b0460","doi-asserted-by":"crossref","first-page":"20211372","DOI":"10.1259\/bjr.20211372","article-title":"Prostate MRI quality: clinical impact of the PI-QUAL score in prostate cancer diagnostic work-up","volume":"95","author":"Karanasios","year":"2022","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.ejrad.2023.110852_b0465","doi-asserted-by":"crossref","first-page":"110431","DOI":"10.1016\/j.ejrad.2022.110431","article-title":"Impact of PI-QUAL on PI-RADS and cancer yield in an MRI-TRUS fusion biopsy population","volume":"154","author":"P\u00f6tsch","year":"2022","journal-title":"Eur. J. Radiol."},{"issue":"5","key":"10.1016\/j.ejrad.2023.110852_b0470","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.eururo.2021.06.026","article-title":"Effects of magnetic resonance imaging targeting on overdiagnosis and overtreatment of prostate cancer","volume":"80","author":"Vickers","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejrad.2023.110852_b0475","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1007\/s00330-022-09097-4","article-title":"Towards a judicious use of perilesional biopsy in the era of MRI-targeting, parting of the ways from systematic prostate biopsy","volume":"32","author":"Padhani","year":"2022","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2023.110852_b0480","doi-asserted-by":"crossref","first-page":"7488","DOI":"10.1007\/s00330-022-09096-5","article-title":"Should we combine systematic with MRI-targeted biopsy? implications for the management of patients with prostate cancer","volume":"32","author":"Gandaglia","year":"2022","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2023.110852_b0485","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.urology.2021.06.008","article-title":"Robot-assisted magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy","volume":"155","author":"Lee","year":"2021","journal-title":"Urology"},{"issue":"8","key":"10.1016\/j.ejrad.2023.110852_b0490","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s11548-021-02437-7","article-title":"Toward autonomous robotic prostate biopsy: a pilot study","volume":"16","author":"Maris","year":"2021","journal-title":"Int. J. Comput. Assist. Radiol. Surg."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X23001663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X23001663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:36:16Z","timestamp":1759995376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X23001663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":98,"alternative-id":["S0720048X23001663"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2023.110852","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MRI-informed prostate biopsy: What the radiologist should know on quality in biopsy planning and biopsy acquisition","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2023.110852","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110852"}}